Covigilant Research, LLC Clinical Trials Site Management Organization

Covigilant Research, LLC

Committed To Working Together

Meissa’s intranasal Covid-19 shot induces robust antibody response in trial,

… generated a robust nasal IgA antibody response in Phase I trial. … in seropositive and seronegative adults in Phase I clinical trial., … generated a robust nasal IgA antibody response in Phase I trial. … in seropositive and seronegative adults in Phase I clinical trial., Read More

Scroll to Top